XJ02862-S2
XJ02862-S2 shows potent FXR agonistic activity. XJ02862-S2 is a promising lead compound for the research of NAFLD[1].
Product Specifications
CAS Number
3023355-55-4
UNSPSC
12352005
Target
FXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/xj02862-s2.html
Solubility
10 mM in DMSO
Smiles
C[C@H]1C[C@H](C2=CC=CC=C2N1C([C@@H](N3C(C4CCCCC4C3=O)=O)C)=O)NC5=CC=CC=C5
Molecular Formula
C27H31N3O3
Molecular Weight
445.55
References & Citations
[1]Tong Qin, et al. Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease. Eur J Med Chem. 2023 Apr 5;252:115307.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![N- (3-Phenyl-4,5,6,7-tetrahydrobenzo[d]thiazol-2 (3H) -ylidene) aniline](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
sc-269641 10 mg
N- (3-Phenyl-4,5,6,7-tetrahydrobenzo[d]thiazol-2 (3H) -ylidene) aniline
Sign In for Pricing
View Details 